X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (27) 27
male (27) 27
humans (26) 26
gastroenterology & hepatology (24) 24
middle aged (21) 21
aged (18) 18
adult (16) 16
index medicus (15) 15
chronic hepatitis c (13) 13
animals (12) 12
interferon (11) 11
rats (11) 11
alpha (9) 9
genotype (9) 9
hepatitis c (9) 9
hepatology (9) 9
ribavirin (9) 9
analysis (8) 8
care and treatment (8) 8
colorectal surgery (8) 8
gastroenterology (8) 8
genetic aspects (8) 8
hepatitis (8) 8
hepatitis c virus (8) 8
hepatitis c, chronic - drug therapy (8) 8
medicine & public health (8) 8
risk factors (8) 8
surgical oncology (8) 8
antiviral agents - therapeutic use (7) 7
biological response modifiers (7) 7
drug therapy, combination (7) 7
hepatocellular-carcinoma (7) 7
infection (7) 7
interferon-alpha - therapeutic use (7) 7
liver (7) 7
oncology (7) 7
retrospective studies (7) 7
survival (7) 7
treatment outcome (7) 7
adolescent (6) 6
cirrhosis (6) 6
hepatitis c, chronic - virology (6) 6
japan - epidemiology (6) 6
ribavirin - therapeutic use (6) 6
rna (6) 6
internal medicine (5) 5
japan (5) 5
liver cirrhosis (5) 5
medical research (5) 5
medicine, experimental (5) 5
necrosis (5) 5
prospective studies (5) 5
time factors (5) 5
aged, 80 and over (4) 4
antiviral agents - administration & dosage (4) 4
chronic active hepatitis (4) 4
cohort studies (4) 4
dna (4) 4
expression (4) 4
fibrosis (4) 4
follow-up (4) 4
hepacivirus - genetics (4) 4
hepatocellular carcinoma (4) 4
incidence (4) 4
interferon therapy (4) 4
interferon-alpha - administration & dosage (4) 4
kupffer cells - metabolism (4) 4
liver - pathology (4) 4
liver fibrosis (4) 4
patients (4) 4
perfusion (4) 4
polyethylene glycols - administration & dosage (4) 4
polyethylene glycols - therapeutic use (4) 4
randomized-trial (4) 4
rats, sprague-dawley (4) 4
recombinant proteins - therapeutic use (4) 4
ribavirin - administration & dosage (4) 4
rna, viral - blood (4) 4
therapy (4) 4
viral load (4) 4
abdominal surgery (3) 3
alcohol (3) 3
anemia (3) 3
antigens (3) 3
antiviral agents - adverse effects (3) 3
autoimmune hepatitis (3) 3
carcinoma, hepatocellular - epidemiology (3) 3
case-control studies (3) 3
cells (3) 3
cells, cultured (3) 3
chronic hepatitis-c (3) 3
diagnosis (3) 3
disease (3) 3
disease progression (3) 3
dose-response relationship, drug (3) 3
ethanol - pharmacology (3) 3
follow-up studies (3) 3
gastroenterology and hepatology (3) 3
genotype & phenotype (3) 3
hemodynamics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 7/2015, Volume 50, Issue 7, pp. 785 - 794
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 3/2016, Volume 51, Issue 3, pp. 252 - 259
Hyperbilirubinemia, mild or moderate, is a commonly observed laboratory abnormality in chronic hepatitis C patients treated with simeprevir with pegylated... 
Pegylated interferon plus ribavirin | Simeprevir | Chronic hepatitis C | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Inosine triphosphate pyrophosphatase | Surgical Oncology | Bilirubin increase | VARIANTS | PHASE-3 | PEGINTERFERON | ALPHA 2A | PROTECT | THERAPY | DOUBLE-BLIND | INFECTION | ANEMIA | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Recombinant Proteins - therapeutic use | Prospective Studies | Humans | Middle Aged | Pyrophosphatases - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Simeprevir - therapeutic use | Simeprevir - adverse effects | Hyperbilirubinemia - chemically induced | Female | Drug Therapy, Combination | Hyperbilirubinemia - genetics | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Risk Factors | Interferon-alpha - therapeutic use | Hemoglobins - metabolism | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Bilirubin - blood | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Hyperbilirubinemia - blood | Interferon alpha-2 | Aged | Interferon-alpha - adverse effects | Care and treatment | Analysis | Hemoglobin | Interferon | Genetic aspects | Bilirubin | Biological response modifiers | Hepatitis C | Ribavirin
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0136908
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2014, Volume 49, Issue 4, pp. 737 - 747
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 7/2011, Volume 46, Issue 7, pp. 944 - 952
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e71382
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2014, Volume 12, Issue 7, pp. 1186 - 1195
Journal Article